Daxor Corporation To Present Compelling New Data and Clinical Trials Utilizing the BVA-100® Blood Test at the Heart Failure Society of America Annual Scientific Meeting 2021
08. September 2021 08:30 ET
|
Daxor Corporation
Oak Ridge, TN, Sept. 08, 2021 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE: DXR), the global leader in blood volume measurement technology, , today announced it will exhibit at the Heart Failure...
Daxor Corporation to Exhibit at the 23rd Annual Scientific Meeting of the Heart Failure Society of America
11. September 2019 08:00 ET
|
Daxor Corporation
NEW YORK, Sept. 11, 2019 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR) an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume...